Warning: Declaration of Custom_Menu_Wizard_Walker::walk($elements, $max_depth) should be compatible with Walker::walk($elements, $max_depth, ...$args) in /home/customer/www/ihcproviders.com/public_html/wdpr/wp-content/plugins/custom-menu-wizard/include/class.walker.php on line 55

Warning: Declaration of Custom_Menu_Wizard_Sorter::walk($elements, $max_depth = 0) should be compatible with Walker::walk($elements, $max_depth, ...$args) in /home/customer/www/ihcproviders.com/public_html/wdpr/wp-content/plugins/custom-menu-wizard/include/class.sorter.php on line 60
Dr. David Baskin Neurosurgery and Spine Surgery - International HealthCare Providers
Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/ihcproviders.com/public_html/wdpr/wp-content/plugins/q-and-a/inc/functions.php on line 252

Dr. David Baskin, MD, FAANS, FAC

Kenneth R. Peak Presidential Distinguished Chair & Program Director, Neurosurgery Residency, Department of Neurosurgery

Professor of Neurosurgery, Institute for Academic Medicine
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College

Neurosurgery, Spine Surgery

Stroke, Neurological surgery & Brain tumors
Dr. Baskin has received many national and international honors and awards. He has served as principal investigator on numerous research projects funded by private, state and federal sources, resulting in multiple patents and patent applications. He has also chaired or served on review panels and advisory councils for private, state and federal agencies. Dr. Baskin has published over 100 scientific manuscripts and book chapters and currently serves as Program Director in Houston Methodist Neurological Institute, as well as Professor of Neurosurgery at Weill Cornell Medical College, and Research Professor at the University of Houston in both the Cullen College of Engineering’s Department of Electrical and Computer Engineering and the School of Pharmacy.
The long-term goals of the Neurosurgery Research Laboratory are to elucidate the DNA mechanisms in various types of neurological disease, and to develop novel diagnostics and treatments for primary brain tumors and autistic spectrum disorder. Dr. Baskin has recently developed methodologies to quantify the levels of different types of DNA damage and of labeled antibody staining in the field of fluorescence microscopy, using a new type of labeled tissue phantoms. His laboratory has introduced innovative techniques that allow the quantification of five different types of DNA damage; blunt ended breaks, overhanging breaks, 3’OH ends and nicks, 3’PO4 ends and nicks and also damaged/oxidized DNA bases. These techniques are in the process of being patented.
In addition, and in conjunction with these tools for examining DNA damage, his research group is pursuing mitochondrially targeted chemotherapeutic agents. These pro-drug agents are activated by enzyme systems known to be up-regulated in certain cancers. The active drug then attacks mitochondrial DNA and mitochondrial RNA; causing loss of mitochondria and cell death. In collaboration with Dr. James Tour, of the Smalley Institute for Nanoscale Science and Technology at Rice University, Dr. Baskin’s group is investigating the use of nanoscale carbon clusters in numerous biomedical applications including as a means to deliver chemotherapeutic agents that are targeted specifically to cancer cells, as well as use as cellular protective agents.
The relationship between environmental pollutants and Autism is also a major research topic being pursued by Dr. Baskin and his group. They have been evaluating the role of possible causative agents, including the classical toxin, organic mercury, which he has shown to have high toxicity in a subgroup of autistic individuals. A second class of causative agents being investigated by his group are hormone disrupting agents such as the agro-chemicals DDT and Atrazine. Their preliminary data suggests that there is major difference in the response of cells from autistic individuals, compared to external controls.

If you, a family member, or a friend would like to see Dr. David Baskin contact us today at 1-866-227-8402 or health@ihcproviders.com

CANADIANS PREFERRED RATES at one of the top hospitals in the world.  Contact International Healthcare Providers to find out how we can help you receive a complimentary quote for immediate access to treatment at Houston Methodist Hospital.

IHP: “Screening hospitals and negotiating preferred rates for Canadians so they get safe quality care internationally. You are not in it alone when you choose IHP”